The purpose of this study is to understand the visual outcomes of the investigational intraocular lens (IOL) Model LPYWT0 when compared to the commercially marketed Clareon PanOptix Pro IOL Model PXYWT0.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-08; most recent amendment 2026-07-07.